News, info and tips for living with multiple sclerosis
As you can see, if you’re reading this, The MS Wire has a new look. The idea is to make the site easier to read and navigate. I hope you like this new format. Of course, comments or suggestions for improvements are always welcome. Ed
I’m finished with my second round of Lemtrada (alemtuzumab). Hopefully, this will be the final round of this disease-modifying therapy (DMT) for me, and my final MS treatment of any kind. Though some have required more, most people treated with Lemtrada receive only two rounds. The first round consists of five infusions over five days. The second round, a year later, is three infusions over three days. If it works…Continue Reading
You may have noticed that I’ve been away from this blog fo a while (at least I hope you noticed). There are a couple of reasons for this. As I write this I’m sitting in an infusion chair, two-thirds of the way through my second round of Lemtrada infusions. I’ll have a report in an upcoming blog most. In the meantime, to catch up with me, you can read these…Continue Reading
I got a phone call from my MS One to One nurse, Lynn, a few days ago. One to One is the patient support service provided by Sanofi Genzyme for patients on the biotech company’s MS disease-modifying therapies (DMTs) Lemtrada (alemtuzumab) and Aubagio (teriflunomide). Lynn called to ensure that all of the paperwork was up-to-date and ready for my second round of Lemtrada infusions, which is scheduled to begin the…Continue Reading
After I wrote about pediatric MS earlier last week, a reader commented: “I think it would behoove your editorship to follow up to address to audiences…symptoms that typify the early-age demographic.” That’s a good point. So, I drilled deeper into how MS is handled in people younger than 18 years old and found some very interesting information. Pediatric MS diagnosis To begin with, neurologists have a difficult time diagnosing MS…Continue Reading
The age at which a person is diagnosed with MS is usually between 20 and 50, according to the National Multiple Sclerosis Society. But it can be diagnosed in people much younger. In fact, of the estimated 400,000people with MS in the United States, 8,000-10,000 are under 18 years old. We older folks have some pretty good support systems to which we can turn to learn about our disease and…Continue Reading
The MS Wire has grown over the past year and I’m really glad that so many people have found some useful information here. Now, I’m getting ready to take a leap to a new web host that will give me more flexibility over how The MS Wire looks and is used. The change is supposed to be seamless. Fingers crossed. However, if you have any trouble accessing the blog, or if…Continue Reading
I know, I know. I write about health issues on the internet, so I shouldn’t be discouraging people from looking for answers here. But, searching the internet to match symptoms with a diagnosis can be a real anxiety booster. Emily Sohn makes a solid case for that in a recent article in The Washington Post: “I might have jaw pain, dizziness or a stomach flu that makes me vomit. Before long,…Continue Reading
It’s nice when a negative experience can be turned into one that’s positive. I think that’s the result for a wheelchair-using MS patient following a problem she had at the Mall of America a few days before the Super Bowl. For those not familiar with the Mall of America, it’s a huge shopping mall just outside Minneapolis, Minnesota. Its promotional fact sheet says that the mall covers 5.6 million square feet,…Continue Reading
Have you been in this Catch-22? You had great medical insurance when you were working. But, you’re not working anymore. Your insurance now comes with a $6,000 deductible and it no longer covers any medications. That $6,000 is about a fifth of your yearly income. You took early retirement because of your MS, but the pension you’re getting puts you over the limit to receive Medicaid help. You can’t get Social…Continue Reading